Gensight Biologics (France) Volatility
| SIGHT Stock | EUR 0.24 0.02 7.69% |
Gensight Biologics holds Efficiency (Sharpe) Ratio of -0.0306, which attests that the entity had a -0.0306 % return per unit of risk over the last 3 months. Gensight Biologics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Gensight Biologics' Risk Adjusted Performance of (0.04), market risk adjusted performance of 0.2847, and Standard Deviation of 4.74 to validate the risk estimate we provide. Key indicators related to Gensight Biologics' volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Gensight Biologics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Gensight daily returns, and it is calculated using variance and standard deviation. We also use Gensight's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Gensight Biologics volatility.
Gensight |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Gensight Biologics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Gensight Biologics at lower prices. For example, an investor can purchase Gensight stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Gensight Biologics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with Gensight Stock
Moving against Gensight Stock
Gensight Biologics Market Sensitivity And Downside Risk
Gensight Biologics' beta coefficient measures the volatility of Gensight stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Gensight stock's returns against your selected market. In other words, Gensight Biologics's beta of -0.88 provides an investor with an approximation of how much risk Gensight Biologics stock can potentially add to one of your existing portfolios. Gensight Biologics SA exhibits very low volatility with skewness of 1.86 and kurtosis of 8.91. Gensight Biologics SA is a potential penny stock. Although Gensight Biologics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Gensight Biologics SA. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Gensight instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Gensight Biologics Demand TrendCheck current 90 days Gensight Biologics correlation with market (Dow Jones Industrial)Gensight Beta |
Gensight standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 4.77 |
It is essential to understand the difference between upside risk (as represented by Gensight Biologics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Gensight Biologics' daily returns or price. Since the actual investment returns on holding a position in gensight stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Gensight Biologics.
Gensight Biologics Stock Volatility Analysis
Volatility refers to the frequency at which Gensight Biologics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Gensight Biologics' price changes. Investors will then calculate the volatility of Gensight Biologics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Gensight Biologics' volatility:
Historical Volatility
This type of stock volatility measures Gensight Biologics' fluctuations based on previous trends. It's commonly used to predict Gensight Biologics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Gensight Biologics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Gensight Biologics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Gensight Biologics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Gensight Biologics Projected Return Density Against Market
Assuming the 90 days trading horizon Gensight Biologics SA has a beta of -0.8798 . This usually impliesMost traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Gensight Biologics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Gensight Biologics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Gensight stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Gensight Biologics SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a Gensight Biologics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Gensight Biologics Stock Risk Measures
Assuming the 90 days trading horizon the coefficient of variation of Gensight Biologics is -3270.25. The daily returns are distributed with a variance of 22.76 and standard deviation of 4.77. The mean deviation of Gensight Biologics SA is currently at 3.19. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.9
α | Alpha over Dow Jones | -0.27 | |
β | Beta against Dow Jones | -0.88 | |
σ | Overall volatility | 4.77 | |
Ir | Information ratio | -0.04 |
Gensight Biologics Stock Return Volatility
Gensight Biologics historical daily return volatility represents how much of Gensight Biologics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The enterprise accepts 4.7708% volatility on return distribution over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.8639% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Gensight Biologics Volatility
Volatility is a rate at which the price of Gensight Biologics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Gensight Biologics may increase or decrease. In other words, similar to Gensight's beta indicator, it measures the risk of Gensight Biologics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Gensight Biologics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. GenSight Biologics S.A. was founded in 2012 and is headquartered in Paris, France. GENSIGHT BIOLOGICS is traded on Paris Stock Exchange in France.
Gensight Biologics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Gensight Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Gensight Biologics' price varies over time.
3 ways to utilize Gensight Biologics' volatility to invest better
Higher Gensight Biologics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Gensight Biologics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Gensight Biologics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Gensight Biologics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Gensight Biologics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Gensight Biologics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Gensight Biologics Investment Opportunity
Gensight Biologics SA has a volatility of 4.77 and is 5.55 times more volatile than Dow Jones Industrial. 42 percent of all equities and portfolios are less risky than Gensight Biologics. You can use Gensight Biologics SA to protect your portfolios against small market fluctuations. The stock experiences a very speculative upward sentiment. Check odds of Gensight Biologics to be traded at €0.228 in 90 days.Good diversification
The correlation between Gensight Biologics SA and DJI is -0.17 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Gensight Biologics SA and DJI in the same portfolio, assuming nothing else is changed.
Gensight Biologics Additional Risk Indicators
The analysis of Gensight Biologics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Gensight Biologics' investment and either accepting that risk or mitigating it. Along with some common measures of Gensight Biologics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | 0.2847 | |||
| Mean Deviation | 3.28 | |||
| Coefficient Of Variation | (2,047) | |||
| Standard Deviation | 4.74 | |||
| Variance | 22.5 | |||
| Information Ratio | (0.04) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Gensight Biologics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Gensight Biologics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Gensight Biologics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Gensight Biologics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Gensight Biologics SA.
Additional Tools for Gensight Stock Analysis
When running Gensight Biologics' price analysis, check to measure Gensight Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gensight Biologics is operating at the current time. Most of Gensight Biologics' value examination focuses on studying past and present price action to predict the probability of Gensight Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gensight Biologics' price. Additionally, you may evaluate how the addition of Gensight Biologics to your portfolios can decrease your overall portfolio volatility.